PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för aprepitant. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

9 hits

Bibliografisk träff 2013-03-19

Efficacy of the oral neurokinin-1 receptor antagonist aprepitant administered with ondansetron for the prevention of postoperative nausea and vomiting.

Lim CS, Ko YK, Kim YH, Park SI, Kim JK, Kim MJ, Kim HJ.

Korean J Anesthesiol · research-article; journal article · DOI 10.4097/kjae.2013.64.3.212

Bibliografisk träff 2013-02-01

Antiemetic effectiveness and safety of aprepitant in patients with hematologic malignancy receiving multiday chemotherapy.

Uchida M, Ikesue H, Kato K, Ichinose K, Hiraiwa H, Sakurai A, Takenaka K, Iwasaki H, Miyamoto T, Teshima T, Egashira N, Akashi K, Oishi R.

Am J Health Syst Pharm · journal article · DOI 10.2146/ajhp120363

Bibliografisk träff 2013-01-01

Aprepitant plus palonosetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy.

Gao HF, Liang Y, Zhou NN, Zhang DS, Wu HY.

Intern Med J · clinical trial; journal article · DOI 10.1111/j.1445-5994.2011.02637.x

Bibliografisk träff 2012-11-27

Gastroparesis-associated refractory nausea treated with aprepitant.

Fahler J, Wall GC, Leman BI.

Ann Pharmacother · journal article; case reports · DOI 10.1345/aph.1r484

Bibliografisk träff 2012-10-11

Review of the efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in a range of tumor types.

Aapro MS, Schmoll HJ, Jahn F, Carides AD, Webb RT.

Cancer Treat Rev · research support, non-u.s. gov't; review; journal article · DOI 10.1016/j.ctrv.2012.09.002

Bibliografisk träff 2012-09-18

Aprepitant for management of severe pruritus related to biological cancer treatments: a pilot study.

Santini D, Vincenzi B, Guida FM, Imperatori M, Schiavon G, Venditti O, Frezza AM, Berti P, Tonini G.

Lancet Oncol · clinical trial; journal article · DOI 10.1016/s1470-2045(12)70373-x

Bibliografisk träff 2012-01-19

Effects of the NK1 antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusers.

Walsh SL, Heilig M, Nuzzo PA, Henderson P, Lofwall MR.

Addict Biol · research-article; randomized controlled trial; journal article; research support, n.i.h., extramural · DOI 10.1111/j.1369-1600.2011.00419.x

Bibliografisk träff 2011-12-21

Using aprepitant as secondary antiemetic prophylaxis for cancer patients with cisplatin-induced emesis.

Wu CE, Liaw CC.

Support Care Cancer · journal article · DOI 10.1007/s00520-011-1345-z

Bibliografisk träff 2011-03-17

Aprepitant pharmacokinetics and assessing the impact of aprepitant on cyclophosphamide metabolism in cancer patients undergoing hematopoietic stem cell transplantation.

Bubalo JS, Cherala G, McCune JS, Munar MY, Tse S, Maziarz R.

J Clin Pharmacol · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1177/0091270011398243